9 Results for "

reperfusion-induced ventricular fibrillation

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "reperfusion-induced ventricular fibrillation" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-12753A
CAS No.: 197431-02-0
Purity:  98.73%
Synonyms: SR35021 hydrochloride
Debutyldronedarone hydrochloride (SR35021 hydrochloride) is a Cytochrome P450 enzyme inhibitor and a Thyroid Hormone Receptor inhibitor, and it is a metabolite of Dronedarone (HY-A0016). Debutyldronedarone hydrochloride inhibits the binding of T3 to TRα1 and TRβ1. Debutyldronedarone hydrochloride reduces the incidence of reperfusion-induced ventricular fibrillation in anesthetized rats, while decreasing their heart rate and blood pressure. Debutyldronedarone hydrochloride can be used in studies related to ventricular fibrillation and atrial fibrillation .
loading...
    loading...
Cat. No.: HY-12753S1
CAS No.: 1346598-70-6
Synonyms: SR35021-dd6 hydrochloride
Debutyldronedarone-d6 hydrochloride (SR35021-d6 hydrochloride) is the deuterated-labeled Debutyldronedarone (HY-12753). Debutyldronedarone (SR35021) is a Cytochrome P450 enzyme inhibitor and a Thyroid Hormone Receptor inhibitor, and it is a metabolite of Dronedarone (HY-A0016). Debutyldronedarone inhibits the binding of T3 to TRα1 and TRβ1. Debutyldronedarone reduces the incidence of reperfusion-induced ventricular fibrillation in anesthetized rats, while decreasing their heart rate and blood pressure. Debutyldronedarone can be used in studies related to ventricular fibrillation and atrial fibrillation .
loading...
    loading...
Cat. No.: HY-116500A
CAS No.: 228123-15-7
Target:  

Calcium Channel

Research Areas:  

Cardiovascular Disease

AH-1058 is a newly synthesized antiarrhythmic agent that exhibits significant antiarrhythmic activity by delaying premature ventricular complexes and ventricular fibrillation in experimental arrhythmia models. AH-1058 effectively inhibits both ventricular tachycardia and ventricular fibrillation in the reperfusion-induced arrhythmia model in rats. AH-1058 demonstrates potent calcium channel-blocking effects, suppressing L-type Ca2+ currents in isolated cardiomyocytes.
loading...
    loading...
Cat. No.: HY-12753AR
CAS No.: 197431-02-0
Synonyms: SR35021 hydrochloride (Standard)
Debutyldronedarone hydrochloride (Standard) (SR35021 hydrochloride (Standard)) is the analytical standard of Debutyldronedarone (hydrochloride) (HY-12753A). This product is intended for research and analytical applications. Debutyldronedarone hydrochloride (SR35021 hydrochloride) is a Cytochrome P450 enzyme inhibitor and a Thyroid Hormone Receptor inhibitor, and it is a metabolite of Dronedarone (HY-A0016). Debutyldronedarone hydrochloride inhibits the binding of T3 to TRα1 and TRβ1. Debutyldronedarone hydrochloride reduces the incidence of reperfusion-induced ventricular fibrillation in anesthetized rats, while decreasing their heart rate and blood pressure. Debutyldronedarone hydrochloride can be used in studies related to ventricular fibrillation and atrial fibrillation .
loading...
    loading...
Cat. No.: HY-12753AS
Synonyms: SR35021-d7 hydrochloride
Debutyldronedarone-d7 hydrochloride (SR35021-d7 hydrochloride) is the deuterated-labeled Debutyldronedarone (hydrochloride) (HY-12753A). Debutyldronedarone hydrochloride (SR35021 hydrochloride) is a Cytochrome P450 enzyme inhibitor and a Thyroid Hormone Receptor inhibitor, and it is a metabolite of Dronedarone (HY-A0016). Debutyldronedarone hydrochloride inhibits the binding of T3 to TRα1 and TRβ1. Debutyldronedarone hydrochloride reduces the incidence of reperfusion-induced ventricular fibrillation in anesthetized rats, while decreasing their heart rate and blood pressure. Debutyldronedarone hydrochloride can be used in studies related to ventricular fibrillation and atrial fibrillation .
loading...
    loading...
Cat. No.: HY-12753S
CAS No.: 2070015-16-4
Synonyms: SR35021-d7
Debutyldronedarone-d7 (SR35021-d7) is the deuterated-labeled Debutyldronedarone (HY-12753). Debutyldronedarone (SR35021) is a Cytochrome P450 enzyme inhibitor and a Thyroid Hormone Receptor inhibitor, and it is a metabolite of Dronedarone (HY-A0016). Debutyldronedarone inhibits the binding of T3 to TRα1 and TRβ1. Debutyldronedarone reduces the incidence of reperfusion-induced ventricular fibrillation in anesthetized rats, while decreasing their heart rate and blood pressure. Debutyldronedarone can be used in studies related to ventricular fibrillation and atrial fibrillation .
loading...
    loading...
Cat. No.: HY-123679
CAS No.: 168620-46-0
Research Areas:  

Cardiovascular Disease

FR-168888 is a Na +/H + exchanger (NHE) inhibitor (Ki=6.4 nM) with weak inhibitory activity against Na +/Ca 2+ exchanger and no cardioprotective effects. FR-168888 is widely applicable to studies related to reperfusion-induced ventricular arrhythmias .
loading...
    loading...
Cat. No.: HY-12753
CAS No.: 141626-35-9
Synonyms: SR35021
Debutyldronedarone (SR35021) is a Cytochrome P450 enzyme inhibitor and a Thyroid Hormone Receptor inhibitor, and it is a metabolite of Dronedarone (HY-A0016). Debutyldronedarone inhibits the binding of T3 to TRα1 and TRβ1. Debutyldronedarone reduces the incidence of reperfusion-induced ventricular fibrillation in anesthetized rats, while decreasing their heart rate and blood pressure. Debutyldronedarone can be used in studies related to ventricular fibrillation and atrial fibrillation .
loading...
    loading...
Cat. No.: HY-187612
CAS No.: 168620-45-9
Research Areas:  

Cardiovascular Disease

FR-168888 free base is a Na +/H + exchanger (NHE) inhibitor (Ki=6.4 nM) with weak inhibitory activity against Na +/Ca 2+ exchanger and no cardioprotective effects. FR-168888 free base is widely applicable to studies related to reperfusion-induced ventricular arrhythmias .
loading...
    loading...